
Finland · Biotechnology
Oncos Therapeutics is a biotech company developing cancer therapies based on its next generation oncolytic viruses.
PrivateFor profit
Set against 66 Biotechnology companies in Finland. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 40% of those with a founding year; website ranked #15,593,536 in the world, about 2 visits a month. 1 people list it on LinkedIn, and 272 follow it.
Oncos Therapeutics develops novel cancer therapies based on its next generation oncolytic viruses. Since the onset of our Advanced Therapy Access Program in 2007, 200 patients have undergone tailored treatment suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for our ongoing clinical development.
BiotechnologyHealth CareTherapeutics
What the source datasets report. We have not watched these rounds ourselves.
$5.5M
raised in total across 1 round
Last raised Apr 2010, 16 years ago
Who started it and how it trades.
Everything the source datasets list about Oncos Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
Where2 fields
Size and reach5 fields
Funding, as listed8 fields
About this record2 fields
66 Biotechnology companies in Finland, filtered by size, age and reach, ready to export with emails on Pro.